Masimirembwa CM - Search Results

1

Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans.

Dandara C, Sayi J, Masimirembwa CM, Magimba A, Kaaya S, De Sommers K, Snyman JR, Hasler JA. Dandara C, et al. Among authors: masimirembwa cm. Clin Chem Lab Med. 2002 Sep;40(9):952-7. doi: 10.1515/CCLM.2002.167. Clin Chem Lab Med. 2002. PMID: 12435115

2

Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A.

Dandara C, Masimirembwa CM, Magimba A, Kaaya S, Sayi J, Sommers DK, Snyman JR, Hasler JA. Dandara C, et al. Among authors: masimirembwa cm. Pharmacogenetics. 2003 Jan;13(1):55-8. doi: 10.1097/00008571-200301000-00008. Pharmacogenetics. 2003. PMID: 12544513

3

Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population.

Masimirembwa CM, Johansson I, Hasler JA, Ingelman-Sundberg M. Masimirembwa CM, et al. Pharmacogenetics. 1993 Dec;3(6):275-80. doi: 10.1097/00008571-199312000-00001. Pharmacogenetics. 1993. PMID: 7908586

4

Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A.

Mukanganyama S, Masimirembwa CM, Naik YS, Hasler JA. Mukanganyama S, et al. Among authors: masimirembwa cm. Clin Chim Acta. 1997 Sep 30;265(2):145-55. doi: 10.1016/s0009-8981(97)00104-6. Clin Chim Acta. 1997. PMID: 9385457

5

Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of southern Africa.

Masimirembwa CM, Dandara C, Sommers DK, Snyman JR, Hasler JA. Masimirembwa CM, et al. Pharmacogenetics. 1998 Feb;8(1):83-5. doi: 10.1097/00008571-199802000-00011. Pharmacogenetics. 1998. PMID: 9511185 No abstract available.

6

Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.

Dandara C, Masimirembwa CM, Magimba A, Sayi J, Kaaya S, Sommers DK, Snyman JR, Hasler JA. Dandara C, et al. Among authors: masimirembwa cm. Eur J Clin Pharmacol. 2001 Apr;57(1):11-7. doi: 10.1007/s002280100282. Eur J Clin Pharmacol. 2001. PMID: 11372584

7

The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations.

Bapiro TE, Hasler JA, Ridderström M, Masimirembwa CM. Bapiro TE, et al. Among authors: masimirembwa cm. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. Biochem Pharmacol. 2002. PMID: 12392820

8

Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells.

Bapiro TE, Andersson TB, Otter C, Hasler JA, Masimirembwa CM. Bapiro TE, et al. Among authors: masimirembwa cm. Eur J Clin Pharmacol. 2002 Nov;58(8):537-42. doi: 10.1007/s00228-002-0512-z. Epub 2002 Oct 2. Eur J Clin Pharmacol. 2002. PMID: 12451431

9

Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6.

Masimirembwa CM, Hasler JA, Johansson I. Masimirembwa CM, et al. Eur J Clin Pharmacol. 1995;48(1):35-8. doi: 10.1007/BF00202169. Eur J Clin Pharmacol. 1995. PMID: 7621845

10

Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors.

Masimirembwa CM, Hasler JA. Masimirembwa CM, et al. Biochem Pharmacol. 1994 Nov 1;48(9):1779-83. doi: 10.1016/0006-2952(94)90464-2. Biochem Pharmacol. 1994. PMID: 7980647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters